The global endocarditis treatment market is witnessing significant growth, fueled by an rising prevalence of cardiovascular diseases and the evolution of innovative therapeutic options. The market is segmented based on factors such as therapy modality, indication, and geography. The Western European region currently holds a leading share of the glo